If ADHD is so common, does it really make sense anymore to call it a disorder (a stance some experts support)? Or could it be a part of normal human variation? While most of us will find at least some ...

Jessica Matthews says she was mistreated due to having borderline personality disorder. For some, the diagnosis of a personality disorder can be a route to treatment and understanding. But others ...

It is an ongoing problem, not a passing one. While there are different types of depression, the most common one is major depressive disorder. It consists of episodes during which the symptoms last ...

The Major I Tournament in Madrid is about to begin, so here's how you can ensure you don't miss any of it. The Major I Tournament is kicking off on Thursday, January 30th, at 10 AM Eastern Time.

Michael C. Hall returns in Dexter: Resurrection, with filming underway James Remar as Harry Morgan reprises role; Debra Morgan's future uncertain Harry's guidance crucial for Dexter's recovery ...

Lecanemab's maintenance dosing regimen is now approved for early-stage Alzheimer's, transitioning from biweekly to once every four weeks after 18 months. Phase 2 and 3 trials confirmed lecanemab's ...

With victory at Melbourne Park, Keys is the first women’s singles player to defeat the top two seeds at a major since Svetlana Kuznetsova at Roland Garros 2009 and the first at the AO since Serena ...

By Tania Ganguli For decades, a small but passionate group of academics has offered a potential balm for the fraught relationship between athletics and education at major universities: Allow ...

Treosulfan plus fludarabine is approved for alloHSCT in patients with AML or MDS aged 1 year and older. Clinical trial results showed improved overall survival with treosulfan compared to busulfan ...

Wooden posts supporting the puppets include the words “child killer.” Ald. Debra Silverstein (50th), the City Council’s lone Jewish member, said she asked Cultural Affairs and Special Events ...

Citation: Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment (2025, January 22) retrieved 15 February 2025 from https://medicalxpress.com ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...